Jiangsu Yahong Meditech Co., Ltd. (SHA:688176)
China · Delayed Price · Currency is CNY 12.30
-0.07 (-0.57%)
Feb 4, 2026, 10:14 AM CST
Jiangsu Yahong Meditech Revenue
Jiangsu Yahong Meditech had revenue of 86.17M CNY in the quarter ending September 30, 2025, with 47.41% growth. This brings the company's revenue in the last twelve months to 279.02M, up 86.37% year-over-year. In the year 2024, Jiangsu Yahong Meditech had annual revenue of 201.56M with 1,365.55% growth.
Revenue (ttm)
279.02M
Revenue Growth
+86.37%
P/S Ratio
24.94
Revenue / Employee
713.60K
Employees
399
Market Cap
6.96B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 201.56M | 187.81M | 1,365.55% |
| Dec 31, 2023 | 13.75M | 13.73M | 52,604.89% |
| Dec 31, 2022 | 26.10K | 21.52K | 470.51% |
| Dec 31, 2021 | 4.57K | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| HPGC Renmintongtai Pharmaceutical | 10.22B |
| Northeast Pharmaceutical Group | 6.85B |
| Hunan Jiudian Pharmaceutical | 3.05B |
| Shandong Wit Dyne Health | 2.36B |
| HARBIN GLORIA PHARMACEUTICALS Co., LTD | 2.25B |
| Jiuzhitang | 1.94B |
| Zhejiang AngLiKang Pharmaceutical CO.,LTD. | 1.45B |
| Hunan Er-Kang Pharmaceutical | 1.29B |